Sage Journals: Discover world-class research

Open access

Research article

First published 2023

Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study

Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen [...]

Therapeutic Advances in Drug Safety

Open access

Research article

First published 2025

Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter,observational,real-world study

Die Sang, Yanfang Su, Yurong Zhang [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2022

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines

Christine Simmons, Daniel Rayson, Anil Abraham Joy [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2026

Economic Evaluation of Inavolisib Combined With Palbociclib–Fulvestrant for PIK3CA-Mutated,HR+/HER2− Advanced Breast Cancer in USA

Hanqing Zeng, Li-Ying Song, Ren Guo [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2021

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

Laura Pizzuti, Eriseld Krasniqi, Isabella Sperduti [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2025

Capivasertib/Fulvestrant in patients with HR+,HER2-low or HER2-negative locally advanced or metastatic breast cancer

Karam Aboud, Magda Meissner, Rob Jones

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2026

Focusing on the Advances and Challenges of HER2-Targeted Therapy: Cutting-Edge Breakthroughs in Neoadjuvant Treatment for HER2-Positive Breast Cancer

Anqi Shang, Yunjing Xiong, Min Li [...]

Technology in Cancer Research & Treatment

Retricted access

Review article

First published 2019-5

Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer Patients

Kaitlin Rascon, Goran Flajc, Carmine De Angelis [...]

Annals of Pharmacotherapy

Open access

Review article

First published 2024

Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer

Sijia Wu, Junnan Xu, Yiwen Ma [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Real-World Experience of HER2-Positive Advanced Breast Cancer (ABC) Treatment and Evaluation of Blood Biomarkers in a Public Institution in Latin America (LATAM)

Guillermo Valencia, Patricia Rioja, Olenka Peralta [...]

Breast Cancer: Basic and Clinical Research

Search results